The effects of transfection reagent polyethyleneimine (PEI) and non-targeting control siRNAs on global gene expression in human aortic smooth muscle cells

BMC Genomics

Volumn 17, Issue 1, 2016, Pages

  Raof, Nurazhani A ^a   Rajamani, Deepa ^a   Chu, Hsun Chieh ^a,b   Gurav, Aniket ^a   Johnson, Joel M ^a   LoGerfo, Frank W ^a   Bhasin, Manoj ^a   Pradhan Nabzdyk, Leena ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Control siRNA; PEI; RNAi; Transfection reagent

Indexed keywords

INTERLEUKIN 1; POLYETHYLENEIMINE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR EZH2; TRANSCRIPTION FACTOR GATA 4; EZH2 PROTEIN, HUMAN; POLYCOMB REPRESSIVE COMPLEX 2;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; NEXT GENERATION SEQUENCING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMS BIOLOGY; UPREGULATION; VASCULAR SMOOTH MUSCLE CELL; AORTA; BIOLOGY; BIOSYNTHESIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HIGH THROUGHPUT SEQUENCING; METABOLISM; PROCEDURES; VASCULAR SMOOTH MUSCLE;

AORTA; COMPUTATIONAL BIOLOGY; ENHANCER OF ZESTE HOMOLOG 2 PROTEIN; GATA4 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION; GENE SILENCING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INTERLEUKIN-1; MUSCLE, SMOOTH, VASCULAR; POLYCOMB REPRESSIVE COMPLEX 2; POLYETHYLENEIMINE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84956926249     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/s12864-015-2267-9     Document Type: Article

References (42)

1. Monahan TS, Andersen ND, Martin MC, Malek JY, Shrikhande GV, Pradhan L, et al. MARCKS silencing differentially affects human vascular smooth muscle and endothelial cell phenotypes to inhibit neointimal hyperplasia in saphenous vein. FASEB J. 2009;23(2):557-64.
2. Yoshida S, Nabzdyk CS, Pradhan L, LoGerfo FW. Thrombospondin-2 gene silencing in human aortic smooth muscle cells improves cell attachment. J Am Coll Surgeons. 2011;213(5):668-76.
3. Nabzdyk CS, Chun MC, Oliver-Allen HS, Pathan SG, Phaneuf MD, You JO, et al. Gene silencing in human aortic smooth muscle cells induced by PEI-siRNA complexes released from dip-coated electrospun poly(ethylene terephthalate) grafts. Biomaterials. 2014;35(9):3071-9.
4. Junaid Malek TM, Andersen ND, Wu SQ, Contreras MA, LoGerfo FW. Selective isolation of anastomotic intimal hyperplasia for microarray analysis by laser capture microdissection. Ledyard, Connecticut: New England Society of Vascular Surgery; 2007.
5. Nimesh S. Polyethylenimine as a promising vector for targeted siRNA delivery. Curr Clin Pharmacol. 2012;7(2):121-30.
6. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159-75.
7. Zhang YB, Niu HT, Chang JW, Dong GL, Ma XB. EZH2 silencing by RNA interference inhibits proliferation in bladder cancer cell lines. Eur J Cancer Care. 2011;20(1):106-12.
8. Chan CT, Moore JP, Budzyn K, Guida E, Diep H, Vinh A, et al. Reversal of vascular macrophage accumulation and hypertension by a CCR2 antagonist in deoxycorticosterone/salt-treated mice. Hypertension. 2012;60(5):1207-12.
9. Lv L, Meng Q, Ye M, Wang P, Xue G. STAT4 deficiency protects against neointima formation following arterial injury in mice. J Mol Cell Cardiol. 2014;74:284-94.
10. Kim J, Kim Y, Kim HT, Kim DW, Ha Y, Kim J, et al. TC1(C8orf4) is a novel endothelial inflammatory regulator enhancing NF-kappaB activity. J Immunol. 2009;183(6):3996-4002.
11. Schultz K, Murthy V, Tatro JB, Beasley D. Endogenous interleukin-1 alpha promotes a proliferative and proinflammatory phenotype in human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2007;292(6):H2927-34.
12. Yang HY, Vonk LA, Licht R, van Boxtel AM, Bekkers JE, Kragten AH, et al. Cell type and transfection reagent-dependent effects on viability, cell content, cell cycle and inflammation of RNAi in human primary mesenchymal cells. Eur J Pharm Sci. 2014;53:35-44.
13. Debey S, Meyer-Kirchrath J, Schror K. Regulation of cyclooxygenase-2 expression by iloprost in human vascular smooth muscle cells. Role of transcription factors CREB and ICER. Biochem Pharmacol. 2003;65(6):979-88.
14. Nencioni A, da Silva RF, Fraga-Silva RA, Steffens S, Fabre M, Bauer I, et al. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. Thromb Haemost. 2014;111(2):308-22.
15. Hallegua DS, Weisman MH. Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis. 2002;61(11):960-7.
16. Chmielewski S, Olejnik A, Sikorski K, Pelisek J, Blaszczyk K, Aoqui C, et al. STAT1-dependent signal integration between IFNgamma and TLR4 in vascular cells reflect pro-atherogenic responses in human atherosclerosis. PLoS One. 2014;9(12), e113318.
17. Azhikina T, Kozlova A, Skvortsov T, Sverdlov E. Heterogeneity and degree of TIMP4, GATA4, SOX18, and EGFL7 gene promoter methylation in non-small cell lung cancer and surrounding tissues. Cancer Genet. 2011;204(9):492-500.
18. Chia NY, Deng N, Das K, Huang D, Hu L, Zhu Y, et al. Regulatory crosstalk between lineage-survival oncogenes KLF5, GATA4 and GATA6 cooperatively promotes gastric cancer development. Gut. 2014.
19. Hellebrekers DM, Lentjes MH, van den Bosch SM, Melotte V, Wouters KA, Daenen KL, et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res. 2009;15(12):3990-7.
20. Muiya NP, Wakil SM, Tahir AI, Hagos S, Najai M, Gueco D, et al. A study of the role of GATA4 polymorphism in cardiovascular metabolic disorders. Human genomics. 2013;7:25.
21. Matsuoka R. GATA4 mutation and congenital cardiovascular diseases: importance of phenotype and genetic background clarification. J Mol Cell Cardiol. 2007;43(6):667-9.
22. Baum P, Fundel-Clemens K, Kreuz S, Kontermann RE, Weith A, Mennerich D, et al. Off-target analysis of control siRNA molecules reveals important differences in the cytokine profile and inflammation response of human fibroblasts. Oligonucleotides. 2010;20(1):17-26.
23. Nabzdyk CS, Chun M, Pradhan L, Logerfo FW. High throughput RNAi assay optimization using adherent cell cytometry. J Transl Med. 2011;9:48.
24. Nabzdyk CS, Chun M, Pradhan Nabzdyk L, Yoshida S, LoGerfo FW. Differential susceptibility of human primary aortic and coronary artery vascular cells to RNA interference. Biochem Biophys Res Commun. 2012;425(2):261-5.
25. Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25(9):1105-11.
26. Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139-40.
27. Huang da W, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, et al. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(Web Server issue):W169-75.
28. Kramer A, Green J, Pollard Jr J, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 2014;30(4):523-30.
29. Andersen ND, Monahan TS, Malek JY, Jain M, Daniel S, Caron LD, et al. Comparison of gene silencing in human vascular cells using small interfering RNAs. J Am Coll Surg. 2007;204(3):399-408.
30. Bustin SA. Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. J Mol Endocrinol. 2002;29(1):23-39.
31. Klein RD, Van Pelt CS, Sabichi AL, Dela Cerda J, Fischer SM, Furstenberger G, et al. Transitional cell hyperplasia and carcinomas in urinary bladders of transgenic mice with keratin 5 promoter-driven cyclooxygenase-2 overexpression. Cancer Res. 2005;65(5):1808-13.
32. Rigato I, Bauce B, Rampazzo A, Zorzi A, Pilichou K, Mazzotti E, et al. Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy. Circulation Cardiovascular genetics. 2013;6(6):533-42.
33. Van der Aa N, Vandeweyer G, Kooy RF. A boy with mental retardation, obesity and hypertrichosis caused by a microdeletion of 19p13.12. European journal of medical genetics. 2010;53(5):291-3.
34. Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, et al. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope. 2000;110(3 Pt 1):374-81.
35. Orozco-Sevilla V, Naftalovich R, Hoffmann T, London D, Czernizer E, Yang C, et al. Epigallocatechin-3-gallate is a potent phytochemical inhibitor of intimal hyperplasia in the wire-injured carotid artery. J Vasc Surg. 2013;58(5):1360-5.
36. Lorenzon E, Colladel R, Andreuzzi E, Marastoni S, Todaro F, Schiappacassi M, et al. MULTIMERIN2 impairs tumor angiogenesis and growth by interfering with VEGF-A/VEGFR2 pathway. Oncogene. 2012;31(26):3136-47.
37. Guemann AS, Andrieux J, Petit F, Halimi E, Bouquillon S, Manouvrier-Hanu S, et al. ELN gene triplication responsible for familial supravalvular aortic aneurysm. Cardiol Young. 2014;1-6.
38. Ohashi M, Runge MS, Faraci FM, Heistad DD. MnSOD deficiency increases endothelial dysfunction in ApoE-deficient mice. Arterioscler Thromb Vasc Biol. 2006;26(10):2331-6.
39. Tiberio L, Nascimbeni R, Villanacci V, Casella C, Fra A, Vezzoli V, et al. The decrease of mineralcorticoid receptor drives angiogenic pathways in colorectal cancer. PLoS One. 2013;8(3), e59410.
40. Bene NC, Alcaide P, Wortis HH, Jaffe IZ. Mineralocorticoid receptors in immune cells: Emerging role in cardiovascular disease. Steroids. 2014.
41. Grundmann S, Hoefer I, Ulusans S, Bode C, Oesterle S, Tijssen JG, et al. Granulocyte-macrophage colony-stimulating factor stimulates arteriogenesis in a pig model of peripheral artery disease using clinically applicable infusion pumps. J Vasc Surg. 2006;43(6):1263-9.
42. Dennis NA, Jones GT, Chong YH, van Rij AM, McLennan IS. Serum anti-Mullerian hormone (AMH) levels correlate with infrarenal aortic diameter in healthy older men: is AMH a cardiovascular hormone? The Journal of endocrinology. 2013;219(1):13-20.